Q1. How many adult patients and how many children have been treated by your Trust for severe asthma in the last three months?
Q2. How many patients have been treated in the last three months with:
30/04/2020 – 30/07/2020
a. Benralizumab
b. Omalizumab
c. Reslizumab
d. Mepolizumab
(Please provide total patients numbers regardless of disease)
Q3. How many patients have been treated in the last three months, for severe asthma ONLY, with:
a. Dupilumab
b. Upadacitinib
